I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Safety profile of the adjuvanted recombinant zoster vaccine..:
López-Fauqued, M
;
Campora, L
;
Delannois, F
...
Vaccine, 0264-410X, 2019, 37:18, s. 2482-2493. , 2019
Link:
http://urn.kb.se/resolve?urn=urn:nbn:se:bth-17834
RT Journal T1
Safety profile of the adjuvanted recombinant zoster vaccine : Pooled analysis of two large randomised phase 3 trials
UL https://suche.suub.uni-bremen.de/peid=base-ftblekingethallb:oai:DiVA.org:bth-17834&Exemplar=1&LAN=DE A1 López-Fauqued, M A1 Campora, L A1 Delannois, F A1 El Idrissi, M A1 Oostvogels, L A1 De Looze, F. J A1 Diez-Domingo, J A1 Heineman, T. C A1 Lal, H A1 McElhaney, J. E A1 McNeil, S. A A1 Yeo, W A1 Tavares-Da-Silva, F A1 Ahonen, A A1 Avelino-Silva, T. J A1 Barba-Gomez, J. F A1 Sanmartin Berglund, Johan PB Blekinge Tekniska Högskola, Institutionen för hälsa; GSK, Wavre, BEL; GSK, Rixensart, BEL; University of Queensland, AUS; Fundación para el Fomento de la Investigación Sanitaria y Biomédica, ESP; GSK, King of Prussia, USA; ealth Sciences North Research Institute, CAN; Dalhousie University, CAN; University of Wollongong, AUS; University of Tampere, FIN; University of São Paulo, BRA; Instituto Dermatológico de Jalisco, MEX; Elsevier Ltd YR 2019 K1 Reactogenicity K1 Safety K1 Vaccine K1 Varicella-zoster virus K1 placebo K1 varicella zoster vaccine K1 acute kidney failure K1 adult K1 age distribution K1 aged K1 alopecia areata K1 aortic stenosis K1 arthralgia K1 Article K1 atrial fibrillation K1 autoimmune pancreatitis K1 autoimmune thyroiditis K1 backache K1 brain infarction K1 cardiogenic shock K1 cardiopulmonary insufficiency K1 celiac disease K1 cerebrovascular accident K1 chill K1 chronic gastritis K1 chronic obstructive lung disease K1 clinical evaluation K1 cohort analysis K1 controlled study K1 coughing K1 Crohn disease K1 disease course K1 dizziness K1 drug efficacy K1 drug safety K1 erythema nodosum K1 facial nerve paralysis K1 fatigue K1 female K1 fever K1 fibrosing alveolitis K1 follow up K1 glomerulonephritis K1 Graves disease K1 Guillain Barre syndrome K1 headache K1 heart atrium flutter K1 heart failure K1 heart infarction K1 herpes zoster JF Vaccine, 0264-410X, 2019, 37:18, s. 2482-2493 LK http://urn.kb.se/resolve?urn=urn:nbn:se:bth-17834 DO http://urn.kb.se/resolve?urn=urn:nbn:se:bth-17834 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)